Phase
Condition
N/ATreatment
N/AClinical Study ID
Ages 65-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 65 years at the moment of ribociclib+ET initiation
Female/Male gender
Confirmed diagnosis of locally advanced/metastatic not eligible for curative surgeryHR+HER2- BC for whom the treating physician took the decision to initiate treatmentwith ribociclib+IA/FUL in the first or in the second line of the treatment
Patient who initiated treatment with ribociclib+IA/FUL no longer than 4 weeks (28days) prior to written informed consent for this study
Provision of written informed consent.
Exclusion
Exclusion Criteria:
Patients with a life expectancy of less than 3 months per the investigator'sjudgment
Patients participating in any interventional clinical trial that includesinvestigational or marketed products at the time of enrollment. (Patientsparticipating in other investigator initiated research or NIS can be included aslong as their standard of care is not altered by the study)
Patients on active treatment for malignancies other than aBC within 3 years beforeBC diagnosis
Patients with active cardiac disease, or history of cardiac dysfunction, includingprolonged QT interval corrected using Fridericia's formula (QTcF > 450 msec).
Study Design
Study Description
Connect with a study center
Novartis Investigative Site
Arkhangelsk, 163045
Russian FederationActive - Recruiting
Novartis Investigative Site
Barnaul, 656045
Russian FederationActive - Recruiting
Novartis Investigative Site
Bryansk, 241028
Russian FederationActive - Recruiting
Novartis Investigative Site
Chelyabinsk, 454080
Russian FederationActive - Recruiting
Novartis Investigative Site
Ekaterinburg, 620036
Russian FederationActive - Recruiting
Novartis Investigative Site
Irkutsk, 664035
Russian FederationActive - Recruiting
Novartis Investigative Site
Kemerovo, 650036
Russian FederationActive - Recruiting
Novartis Investigative Site
Khabarovsk, 680042
Russian FederationActive - Recruiting
Novartis Investigative Site
Kirov, 610021
Russian FederationActive - Recruiting
Novartis Investigative Site
Krasnoyarsk, 660022
Russian FederationActive - Recruiting
Novartis Investigative Site
Obninsk, 249036
Russian FederationActive - Recruiting
Novartis Investigative Site
Perm, 614066
Russian FederationActive - Recruiting
Novartis Investigative Site
Rostov On Don, 344006
Russian FederationActive - Recruiting
Novartis Investigative Site
St Petersburg, 194291
Russian FederationActive - Recruiting
Novartis Investigative Site
Tver, 170008
Russian FederationActive - Recruiting
Novartis Investigative Site
Ufa, 450054
Russian FederationActive - Recruiting
Novartis Investigative Site
Yaroslavl, 150054
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.